Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Intensive Care|April 28, 2023
Necrotizing soft tissue infections in critically ill neutropenic patients: a French multicentre retrospective cohort studyRomain Arrestier, Anis Chaba, Asma Mabrouki, et al.
Annals of Intensive Care|December 31, 2022
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre studyRomain Arrestier, Paul Bastard, Thibaut Belmondo, et al.
Viruses|July 27, 2022
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort StudySlim Fourati, Etienne Audureau, Romain Arrestier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 2021
The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury, and/or proteinuriaSophie Ferlicot, Matthieu Jamme, François Gaillard, et al.
Annals of Intensive Care|June 1, 2026
Clinical spectrum, outcome and impact of nephrectomy in critically-ill adult patients with emphysematous pyelonephritis: the PYELEMPHY observational retrospective multicenter StudyKeyvan Razazi, Pierre Louis Blot, Amélie Renou, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Pageof 3